WHO Recommends Worldwide Adoption Of All Oral-Regimen For MDR/RR-TB 13/12/2019 Grace Ren The World Health Organization issued new guidelines for the treatment of multi drug-resistant (MDR) tuberculosis on Wednesday, prioritizing for the first time an all-oral treatment regimen. The new treatment recommends replacing the painful injectable drugs that patients had to endure under previous treatment guidelines with a shorter course of oral bedaquiline – one of only […] Continue reading -> Stop TB Partnership Launches New Global Plan, World’s Largest Funding Call For TB Grassroots Organizations, & Pediatric DR-TB Initiative 10/12/2019 Grace Ren A new plan to dramatically accelerate global efforts to end tuberculosis, one of the world’s deadliest and oldest known infectious diseases, was launched Tuesday by the Stop TB Partnership in Jakarta. The fully-costed plan is based on commitments made at a 2018 United Nations High-Level Meeting on Ending TB (UNHLM) to reduce TB deaths by […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Gavi, The Vaccine Alliance Approves New Ebola Vaccine Stockpile Of 500,000 Doses 05/12/2019 Grace Ren Gavi, the Vaccine Alliance approved on Thursday an investment of US$178 million over the next five years to establish a global stockpile of 500,000 doses of Ebola vaccines that have been “pre-qualified” by the World Health Organization – WHO’s quality seal of approval that also makes vaccines and drugs eligible for preferential terms of purchase […] Continue reading -> “Fight The Fakes” Campaign Raises Awareness Of Falsified & Substandard Medicines 03/12/2019 Grace Ren For the second year running, some 37 organizations have launched a week-long mini campaign to raise awareness and promote action against falsified and substandard medicines. This year’s annual Fight the Fakes week aims to mobilize the public and international global health community to speak up more assertively about the growing threat of fake or substandard […] Continue reading -> HIV Treatment For Children To Be Produced For Under One Dollar A Day 02/12/2019 Press release [Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading -> French Parliament To Require Disclosure Of Public Funds Used In R&D For New Drugs Entering Market 27/11/2019 Grace Ren The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Posts navigation Older postsNewer posts
Stop TB Partnership Launches New Global Plan, World’s Largest Funding Call For TB Grassroots Organizations, & Pediatric DR-TB Initiative 10/12/2019 Grace Ren A new plan to dramatically accelerate global efforts to end tuberculosis, one of the world’s deadliest and oldest known infectious diseases, was launched Tuesday by the Stop TB Partnership in Jakarta. The fully-costed plan is based on commitments made at a 2018 United Nations High-Level Meeting on Ending TB (UNHLM) to reduce TB deaths by […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Gavi, The Vaccine Alliance Approves New Ebola Vaccine Stockpile Of 500,000 Doses 05/12/2019 Grace Ren Gavi, the Vaccine Alliance approved on Thursday an investment of US$178 million over the next five years to establish a global stockpile of 500,000 doses of Ebola vaccines that have been “pre-qualified” by the World Health Organization – WHO’s quality seal of approval that also makes vaccines and drugs eligible for preferential terms of purchase […] Continue reading -> “Fight The Fakes” Campaign Raises Awareness Of Falsified & Substandard Medicines 03/12/2019 Grace Ren For the second year running, some 37 organizations have launched a week-long mini campaign to raise awareness and promote action against falsified and substandard medicines. This year’s annual Fight the Fakes week aims to mobilize the public and international global health community to speak up more assertively about the growing threat of fake or substandard […] Continue reading -> HIV Treatment For Children To Be Produced For Under One Dollar A Day 02/12/2019 Press release [Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading -> French Parliament To Require Disclosure Of Public Funds Used In R&D For New Drugs Entering Market 27/11/2019 Grace Ren The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Posts navigation Older postsNewer posts
Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Gavi, The Vaccine Alliance Approves New Ebola Vaccine Stockpile Of 500,000 Doses 05/12/2019 Grace Ren Gavi, the Vaccine Alliance approved on Thursday an investment of US$178 million over the next five years to establish a global stockpile of 500,000 doses of Ebola vaccines that have been “pre-qualified” by the World Health Organization – WHO’s quality seal of approval that also makes vaccines and drugs eligible for preferential terms of purchase […] Continue reading -> “Fight The Fakes” Campaign Raises Awareness Of Falsified & Substandard Medicines 03/12/2019 Grace Ren For the second year running, some 37 organizations have launched a week-long mini campaign to raise awareness and promote action against falsified and substandard medicines. This year’s annual Fight the Fakes week aims to mobilize the public and international global health community to speak up more assertively about the growing threat of fake or substandard […] Continue reading -> HIV Treatment For Children To Be Produced For Under One Dollar A Day 02/12/2019 Press release [Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading -> French Parliament To Require Disclosure Of Public Funds Used In R&D For New Drugs Entering Market 27/11/2019 Grace Ren The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Posts navigation Older postsNewer posts
Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Gavi, The Vaccine Alliance Approves New Ebola Vaccine Stockpile Of 500,000 Doses 05/12/2019 Grace Ren Gavi, the Vaccine Alliance approved on Thursday an investment of US$178 million over the next five years to establish a global stockpile of 500,000 doses of Ebola vaccines that have been “pre-qualified” by the World Health Organization – WHO’s quality seal of approval that also makes vaccines and drugs eligible for preferential terms of purchase […] Continue reading -> “Fight The Fakes” Campaign Raises Awareness Of Falsified & Substandard Medicines 03/12/2019 Grace Ren For the second year running, some 37 organizations have launched a week-long mini campaign to raise awareness and promote action against falsified and substandard medicines. This year’s annual Fight the Fakes week aims to mobilize the public and international global health community to speak up more assertively about the growing threat of fake or substandard […] Continue reading -> HIV Treatment For Children To Be Produced For Under One Dollar A Day 02/12/2019 Press release [Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading -> French Parliament To Require Disclosure Of Public Funds Used In R&D For New Drugs Entering Market 27/11/2019 Grace Ren The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Posts navigation Older postsNewer posts
Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Gavi, The Vaccine Alliance Approves New Ebola Vaccine Stockpile Of 500,000 Doses 05/12/2019 Grace Ren Gavi, the Vaccine Alliance approved on Thursday an investment of US$178 million over the next five years to establish a global stockpile of 500,000 doses of Ebola vaccines that have been “pre-qualified” by the World Health Organization – WHO’s quality seal of approval that also makes vaccines and drugs eligible for preferential terms of purchase […] Continue reading -> “Fight The Fakes” Campaign Raises Awareness Of Falsified & Substandard Medicines 03/12/2019 Grace Ren For the second year running, some 37 organizations have launched a week-long mini campaign to raise awareness and promote action against falsified and substandard medicines. This year’s annual Fight the Fakes week aims to mobilize the public and international global health community to speak up more assertively about the growing threat of fake or substandard […] Continue reading -> HIV Treatment For Children To Be Produced For Under One Dollar A Day 02/12/2019 Press release [Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading -> French Parliament To Require Disclosure Of Public Funds Used In R&D For New Drugs Entering Market 27/11/2019 Grace Ren The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Posts navigation Older postsNewer posts
Gavi, The Vaccine Alliance Approves New Ebola Vaccine Stockpile Of 500,000 Doses 05/12/2019 Grace Ren Gavi, the Vaccine Alliance approved on Thursday an investment of US$178 million over the next five years to establish a global stockpile of 500,000 doses of Ebola vaccines that have been “pre-qualified” by the World Health Organization – WHO’s quality seal of approval that also makes vaccines and drugs eligible for preferential terms of purchase […] Continue reading -> “Fight The Fakes” Campaign Raises Awareness Of Falsified & Substandard Medicines 03/12/2019 Grace Ren For the second year running, some 37 organizations have launched a week-long mini campaign to raise awareness and promote action against falsified and substandard medicines. This year’s annual Fight the Fakes week aims to mobilize the public and international global health community to speak up more assertively about the growing threat of fake or substandard […] Continue reading -> HIV Treatment For Children To Be Produced For Under One Dollar A Day 02/12/2019 Press release [Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading -> French Parliament To Require Disclosure Of Public Funds Used In R&D For New Drugs Entering Market 27/11/2019 Grace Ren The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Posts navigation Older postsNewer posts
“Fight The Fakes” Campaign Raises Awareness Of Falsified & Substandard Medicines 03/12/2019 Grace Ren For the second year running, some 37 organizations have launched a week-long mini campaign to raise awareness and promote action against falsified and substandard medicines. This year’s annual Fight the Fakes week aims to mobilize the public and international global health community to speak up more assertively about the growing threat of fake or substandard […] Continue reading -> HIV Treatment For Children To Be Produced For Under One Dollar A Day 02/12/2019 Press release [Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading -> French Parliament To Require Disclosure Of Public Funds Used In R&D For New Drugs Entering Market 27/11/2019 Grace Ren The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Posts navigation Older postsNewer posts
HIV Treatment For Children To Be Produced For Under One Dollar A Day 02/12/2019 Press release [Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading -> French Parliament To Require Disclosure Of Public Funds Used In R&D For New Drugs Entering Market 27/11/2019 Grace Ren The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Posts navigation Older postsNewer posts
French Parliament To Require Disclosure Of Public Funds Used In R&D For New Drugs Entering Market 27/11/2019 Grace Ren The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Posts navigation Older postsNewer posts
Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Posts navigation Older postsNewer posts